In the last trading session, 1.61 million Niagen Bioscience Inc (NASDAQ:NAGE) shares changed hands as the company’s beta touched 2.15. With the company’s per share price at $9.68 changed hands at -$0.48 or -4.77% during last session, the market valuation stood at $762.49M. NAGE’s last price was a discount, traded about -51.76% off its 52-week high of $14.69. The share price had its 52-week low at $2.53, which suggests the last value was 73.86% up since then. When we look at Niagen Bioscience Inc’s average trading volume, we note the 10-day average is 1.12 million shares, with the 3-month average coming to 1.01 million.

Niagen Bioscience Inc (NASDAQ:NAGE) trade information

Instantly NAGE was in red as seen at the end of in last trading. With action -14.03%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 232.65%, with the 5-day performance at -14.03% in the red. However, in the 30-day time frame, Niagen Bioscience Inc (NASDAQ:NAGE) is -29.75% down. Looking at the short shares, we see there were 3.27 million shares sold at short interest cover period of 3.35 days.

Niagen Bioscience Inc (NASDAQ:NAGE)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 34.44% of Niagen Bioscience Inc shares while 33.09% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 50.48%.

Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 2.12 shares estimated at $20.55 million under it, the former controlled 2.70% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.61% of the shares, roughly 1.27 shares worth around $12.28 million.